DALLAS–(BUSINESS WIRE)–IKS Health, a global leader in care enablement solutions supporting clinicians, staff, and patients at every step of the care journey, is proud to announce a key partnership with GI Alliance, the nation’s largest independent gastroenterology (GI) services organization. Working together and leveraging the IKS Health platform, the partnership will deploy advanced AI-enabled technology … [Read more…]
Study published in American Journal of Transplantation highlights strong sensitivity and specificity, along with a >37% reduction in false positives when using Prospera Heart with DQS Adds to the growing body of evidence supporting DQS for dd-cfDNA analysis in solid organ transplant AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and … [Read more…]
(Stock Code: 4626 JT) *Oasis is very concerned about Taiyo HD’s overall corporate governance and its poor business operations. *Mr. Eiji Sato has led these governance failures and poor business operations, while Mr. Kiyofumi Takano is dispatched from DIC, which Taiyo HD has a conflict of interest *Oasis submitted a shareholder proposal to dismiss Mr. … [Read more…]
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan–(BUSINESS WIRE)–#ClinicalResearch–ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that it has now completed a … [Read more…]
MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 7, 2025, when it announced the Initial Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025, it has made application to the … [Read more…]
ROCHESTER, N.Y.–(BUSINESS WIRE)–Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement, and control instrumentation, announced that it will release its fourth quarter fiscal year 2025 results after the close of financial markets on … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Market for Metal-Organic Frameworks (MOFs) 2025-2035” report has been added to ResearchAndMarkets.com’s offering. Metal-organic frameworks (MOFs) represent one of the most promising classes of advanced materials developed in recent decades, characterized by their tunable porous structures, exceptional surface areas, and customizable chemical functionalities. Despite over 100,000 MOF structures having been synthesized in … [Read more…]
SAN FRANCISCO–(BUSINESS WIRE)–Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized Capital, including participation from Argon Ventures and Lowercarbon Capital. Trilobio was founded in 2021 to address the established data quality and reproducibility challenges limiting … [Read more…]
Gallman’s Appointment is Effective Immediately Sandra Leung, Executive Vice President, General Counsel Retires After 33 Years of Service PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after … [Read more…]
ETH47 is a first-in-class mRNA antiviral therapy with broad-spectrum potential The project will generate key preclinical and clinical data to validate ETH47’s potential in combating a broad range of respiratory and systemic infections and via several routes of administration MUNICH–(BUSINESS WIRE)–Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced that … [Read more…]
